Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study - Persico, Marcello; Aglitti, Andrea; Milella, Michele; Coppola, Carmine; Messina, Vincenzo; Claar, Ernesto; Gentile, Ivan; Sogari, Fernando; Pierri, Paola; Surace, Lorenzo A.; Morisco, Filomena; Tundo, Paolo; et al. (Liver international, 2019)
Keywords: Adult; Aged; Aged, 80 and over; Antiviral agents; Antiviral Agents - therapeutic use; Benzimidazoles - therapeutic use; cirrhosis; Correlation analysis; Creatinine; direct‐acting antiviral; Drug abuse; Drug Therapy, Combination; Effectiveness; efficacy; Epidemics; Female; Fibrosis; Genotype; Genotypes; HCV genotype; Hepacivirus - drug effects; Hepacivirus - genetics; Hepatitis; Hepatitis C; Hepatitis C, Chronic - drug therapy; Humans; Italy; Kidney diseases; Liver Cirrhosis - virology; Longitudinal Studies; Male; Medical treatment; Middle Aged; Patients; Prospective Studies; Quinoxalines - therapeutic use; Subgroups; substance abuse; Substance Abuse, Intravenous - complications; Substance use; Sulfonamides - therapeutic use; Sustained Virologic Response; Viruses; Young Adult; Italy; direct-acting antiviral; substance abuse; cirrhosis; efficacy; HCV genotype